BDRX

NASD Biodexa Pharmaceuticals plc Sponsored ADR

Oct 13, 2026 · 1:19 AM ET EOD Market Closed

$0.3832 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3832, $0.0868 below the day’s high of $0.4700

YTD change: -96.62%
vs 20-day SMA: -46.52%
vs 200-day SMA: -90.56%

Price ranges

Previous day

$0.4500 $0.5200

open $0.5200 close $0.4602

-$0.0598 (-11.50%)

Today

$0.3780 $0.4700

open $0.4700 now $0.3832

-$0.0868 (-18.47%)

Past week

$0.4500 $0.6360

from $0.6199 now $0.3832

-$0.2367 (-38.18%)

Past month

$0.4500 $1.4600

from $1.3000 now $0.3832

-$0.9168 (-70.52%)

This year

$0.3780 $11.3500

from $11.3500 now $0.3832

-$10.9668 (-96.62%)

Price & Performance

-2.72 (-87.64%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 100.0% away from all-time highs of $163,000.0000
BDRX is down 97% since the beginning of the year
BDRX is down 99% over the past 12 months
BDRX is down 71% over the past 1 month
7% of all BDRX investors are betting against BDRX

BDRX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -95.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A

EPS N/A

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $3.4B

Beta 2.35

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$4.3M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $1.6M

Biodexa Pharmaceuticals Plc is a drug delivery technology company. The firm is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. Its proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,182.62	+0.28%
JNJ	Johnson & Johnson	$263.73	+0.88%
ABBV	AbbVie, Inc.	$281.12	+1.68%
MRK	Merck & Co., Inc.	$145.45	-0.10%
RHHBY	Roche Holding Ltd Sponsored ADR	$54.10	+0.02%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.